- $11.2 BnWorld market, 2023
- $35.5 BnProjected, 2033
- 12.2%Growth a year (CAGR)
- 342Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$4.7 Bn
10.2% a year · 42% of the world -
2
China
$903 Mn
13.7% a year · 8% of the world -
3
Canada
$898 Mn
12.2% a year · 8% of the world -
4
Japan
$698 Mn
12.7% a year · 6.2% of the world -
5
Germany
$411 Mn
10.4% a year · 3.7% of the world -
6
France
$309 Mn
11.2% a year · 2.7% of the world -
7
UK
$292 Mn
10.2% a year · 2.6% of the world -
8
Brazil
$281 Mn
13.2% a year · 2.5% of the world -
9
Italy
$270 Mn
11.7% a year · 2.4% of the world -
10
Ecuador
$225 Mn
12.8% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
Spain
AustraliaAtopic Dermatitis Drugs by country and region
India
Saudi Arabia
Mexico
South Africa
UAE
Egypt
Philippines
Malaysia
Hong Kong
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 15,449 papers since 2021
- Beyond the "To Test or Not to Test" Dilemma: Clinical Investigations for Food Allergy in Atopic Dermatitis. International journal of dermatology, 2026
- Development of an α-bisabolol-modified natural oil-based self-emulsifying drug delivery system for enhanced topical delivery of hydrocortisone acetate in a DNCB-induced atopic dermatitis-like mouse model. Nanomedicine : nanotechnology, biology, and medicine, 2026
- Considerations When Caregivers Refuse Topical Corticosteroids for Pediatric Eczema. Journal of the American Academy of Dermatology, 2026
- Air Pollution and Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis. JAMA pediatrics, 2026
- Comment on "Walnut, cashew, and peanut proteins in household dust and sensitization in young children with atopic dermatitis". Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2026
Compare Atopic Dermatitis Drugs side by side
Key companies in Atopic Dermatitis Drugs
Sanofi
Pfizer Inc.
AbbVie
Leo Pharma
Eli Lilly
Teva Pharmaceutical Industries Ltd.
Novartis AG.
Regeneron Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
Galderma S.A.
Dermira, Inc.
Quick answers
How big is the Atopic Dermatitis Drugs market?
The world Atopic Dermatitis Drugs market was worth about $11.2 Bn in 2023 and is projected to reach $35.5 Bn by 2033, growing 12.2% a year (CAGR).
Which country has the largest Atopic Dermatitis Drugs market?
The US is the largest of the 24 countries we cover, at $4.7 Bn in 2023. India grows fastest, at 15.2% a year.
How many clinical trials are running in Atopic Dermatitis Drugs?
ClinicalTrials.gov lists 342 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Atopic Dermatitis Drugs?
PubMed lists about 15,449 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.